Vir Biotechnology, Inc. Quarterly Marketable Securities, Current in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Vir Biotechnology, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2018 to Q2 2024.
  • Vir Biotechnology, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $850M, a 27.2% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $850M -$317M -27.2% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $985M -$421M -30% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $1.27B -$251M -16.5% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $1.23B -$126M -9.29% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $1.17B +$513M +78.4% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $1.41B +$1.01B +252% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.52B +$1.3B +601% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $1.36B +$1.3B +2348% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $654M +$570M +678% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $400M +$188M +88.9% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $217M -$83.1M -27.7% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $55.6M -$309M -84.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $84.1M -$96.5M -53.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $212M +$24.4M +13.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $300M +$26.2M +9.55% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $364M +$138M +60.7% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $181M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $187M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $274M +$223M +439% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $227M Sep 30, 2019 10-Q 2019-11-19
Q4 2018 $50.8M Dec 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.